慢性血栓栓塞性肺动脉高压的治疗

doi:10.3877/cma.j.issn.2095-5782.2020.04.016

中华介入放射学电子杂志 ›› 2020, Vol. 08 ›› Issue (04) : 378 -381. doi: 10.3877/cma.j.issn.2095-5782.2020.04.016

所属专题：文献；

综述

慢性血栓栓塞性肺动脉高压的治疗

魏胜超¹, 邓堂¹, 廖勇¹, 金桂云¹^,^†(

), 王剑锋²^,^†(

)

^1. 571199　海南海口，海南医学院第一附属医院介入血管外科
^2. 100020　北京，首都医科大学附属北京朝阳医院介入放射科

收稿日期:2020-06-10 出版日期:2020-11-25
通信作者: 金桂云, 王剑锋

Treatment of chronic thromboembolic pulmonary hypertension

Shengchao Wei¹, Tang Deng¹, Yong Liao¹, Guiyun Jin¹^,^†(), Jianfeng Wang²^,^†()

^1. Department of Interventional Vascular Surgery, the First Affiliated Hospital of Hainan Medical College, Hainan Haikou 570100
^2. Department of Interventional Radiology, Beijing Chaoyang Hospital of Capital Medical University, Beijing 100020, China

Received:2020-06-10 Published:2020-11-25
Corresponding author: Guiyun Jin, Jianfeng Wang
About author:
Corresponding authors: Jin Guiyun, Email: 13976609625@163.com
Wang Jianfeng, Email: jianfeng_wang@126.com

全文 ( ) 下载PDF ( ) 导出引用

慢性血栓栓塞性肺动脉高压（chronic thromboembolic pulmonary hypertension，CTEPH）是肺动脉的急性血栓没有溶解，从而转化为不溶性纤维血栓阻塞近端动脉，合并部分小动脉出现血管病变，近端和远端小血管阻塞而增加肺血管阻力，导致进行性肺动脉高压，从而引起右心动能衰竭直至死亡，是肺血栓栓塞症的一种特殊类型，也是肺动脉高压的常见类型。CTEPH目前的主要疗法包括肺动脉血栓内膜剥脱术（pulmonary endarterectomy，PEA）、药物治疗、介入治疗等。

关键词: 慢性血栓栓塞性肺动脉高压, 球囊肺动脉成形术, 肺动脉血栓内膜剥脱术

Chronic thromboembolic pulmonary hypertension (CTEPH) is an acute thrombosis of the pulmonary artery that has not been dissolved, which turns into insoluble fibrous thrombosis to block the proximal artery, combined with vascular disease in some small arteries, and blockage of proximal and distal small vessels, increasing pulmonary vascular resistance leads to progressive pulmonary hypertension, which can cause right heart motility failure even death. It is a special type of pulmonary thromboembolism and a common type of pulmonary hypertension. The current main treatments of CTEPH include pulmonary endarterectomy (PEA), drug therapy, and interventional therapy.

Key words: Chronic thromboembolic pulmonary hypertension, Balloon pulmonary angioplasty, Pulmonary thrombo endarterectomy

[1]	Jiménez D, de Miguel-Díez J, Guijarro R, et al. Trends in the management and outcomes of acute pulmonary embolism: analysis from the RIETE registry[J]. J Am Coll Cardiol, 2016, 67(2): 162-170.
[2]	Mayer E.Surgical treatment of chronic thromboembolic pulmonary hypertension[J]. Swiss Med Wkly, 2006, 136(31-32): 491-497.
[3]	Galiè N, Kim NH.Pulmonary microvascular disease in chronic thromboembolic pulmonary hypertension[J]. Proc Am Thorac Soc, 2006, 3(7): 571-576.
[4]	Poli D, Grifoni E, Antonucci E, et al. Incidence of recurrent venous thromboembolism and of chronic thromboembolic pulmonary hypertension in patients after a first episode of pulmonary embolism[J]. J Thromb Thrombolysis, 2010, 30(3): 294-299.
[5]	Martí D, Gómez V, Escobar C, et al. Incidence of symptomatic and asymptomatic chronic thromboembolic pulmonary hypertension[J]. Arch Bronconeumol, 2010, 12(46): 628-633.
[6]	Lang IM, Madani M.Update on chronic thromboembolic pulmonary hypertension[J]. Circulation, 2014, 130(6): 508-518.
[7]	Klok FA, Dzikowska-Diduch O, Kostrubiec M, et al. Derivation of a clinical prediction score for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism[J].Journal of Thrombosis and Haemostasis, 2016, 14(1): 121-128.
[8]	Lewczuk J, Piszko P, Jagas J, et al. Prognostic factors in medically treated patients with chronic pulmonary embolism[J]. Chest, 2001, 119(3): 818-823.
[9]	阮英茆. 常见不同类型肺血管病病理学及从病理资料看临床存在的问题[J]. 心电与循环, 2014, 33(6): 439-441.
[10]	Berger G, Azzam ZS, Hardak E, et al.Idiopathic pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: can we be certain?[J]. Isr Med Assoc J, 2011, 13(2): 106-110.
[11]	Scheidl SJ, Englisch C, Kovacs G, et al. Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients[J]. Eur Ｒespir J, 2012, 39(1): 119-124.
[12]	郭晓曦，综述，张慧敏等. 慢性血栓栓塞性肺动脉高压[J]. 心血管病学进展, 2016, 37(3): 323-328.
[13]	Lang IM. Chronic thromboembolic pulmonary hypertension--not so rare after all[J]. N Engl J Med, 2004, 350(22): 2236-2238.
[14]	Mullin CJ, Klinger JR. Chronic thromboembolic pulmonary hypertension[J]. Heart Fail Clin, 2018, 14(3): 339-351.
[15]	王辰. 肺血栓栓塞症诊治与预防指南[J]. 中华医学杂志, 2018, 98(14): 1060-1087.
[16]	Tunariu N, Gibbs SJR, Win Z, et al.Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension[J]. J Nucl Med, 2007, 48(5): 680-684.
[17]	Piovella F, D'Armini AM, Barone M, et al. Chronic thromboembolic pulmonary hypertension[J]. Semin Thromb Hemost, 2006, 32(8): 848-855.
[18]	Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension[J]. Eur Heart J, 2016, 37(1): 67-119.
[19]	Guth S, Wiedenroth CB, Kramm T, et al.Pulmonary endarterectomy for the treatment of chronic thromboembolic pulmonary hypertension[J]. Expert Rev Respir Med, 2016, 10(6): 673-84.
[20]	Pepke-Zaba J, Delcroix M, Lang I, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry[J]. Circulation, 2011, 124(18): 1973-1981.
[21]	毛源杰. 慢性栓塞性肺动脉高压的药物治疗进展[J]. 现代生物医学进展, 2008, 8(10): 1972-1974.
[22]	Thistlethwaite PA, Auger WR, Medani MM, et al. Pulmonary thromboendarterectomy combined with other cardiac operations: Indications,surgical approach,and outcome[J]. Ann Thorac Surg, 2001, 72(1): 13-19.
[23]	Jamieson SW, Kapelanski DP, Sakakibara N, et al. Pulmonary endarterectomy: experience andlessons learned in 1 500 cases[J].Ann Thorac Surg, 2003, 76(5): 1457-1462.
[24]	Condliffe R, Kiely DG, Gibbs JS,et al.Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension[J]. Am J Respir Crit Care Med, 2008, 177(10): 1122-1127.
[25]	Thistlethwaite PA, Madani MM, Kemp AD, et al. Venovenous extracorporeal life support after pulmonary endarterectomy: indications, techniques, and outcomes[J]. Ann Thorac Surg, 2006, 82(6): 2139-2145.
[26]	Bonderman D, Skoro-Sajer N, Jakowitsch J, et al. Predictors of outcome in chronic thromboembolic pulmonary hypertension[J].Circulation, 2007, 115(16), 2153-2158.
[27]	Neil K, Dunning J. Chronicthromboembolic pulmonary hypertension (CTEPH)[J]. Heart, 2007, 93(9): 1152-1158.
[28]	Bonderman D, Skoro-Sajer NSS, Jakowitsch J, et al. Predictors of outcome in chronic thromboembolic pulmonary hypertension[J].Circulation, 2007, 115(16): 2153-2158.
[29]	Rubens FD, Bourke M, Hynes M,etal.Surgery for chronic thromboembolic pulmonary hypertension inclusive experience from a national referral center[J]. Ann Thorac Surg, 2007, 83(3): 1075-1081.
[30]	Thistlethwaite PA, Madani M, Jamieson SW. Outcomes of pulmonary endarterectomy surgery[J]. Semin Thorac Cardiovasc Surg, 2006, 18(3): 257-264.
[31]	Adams A, Fedullo PF. Postoperative management of the patient undergoing pulmonary endarterectomy[J]. Semin Thorac Cardiovasc Surg, 2006, 18(3): 250-256.
[32]	宋云虎，吴永波，柳志红, 等. 30例肺动脉血栓内膜剥脱术临床结果[J]. 中国循环杂志, 2006, 21(4): 294-296.
[33]	陶传花，吴炳祥. 慢性阻塞性肺疾病相关性肺动脉高压的治疗现状[J]. 心血管康复医学杂志, 2019, 28(4): 509-512.
[34]	Sadushi-Kolici R, Lang IM. Treprostinil for the treatment of chronic thromboembolic pulmonary hypertension[J]. Expert Rev Respir Med, 2019, 23: 1-7.
[35]	Zhang Y, Yu X, Jin Q, et al. Advances in targeted therapy for chronic thromboembolic pulmonary hypertension[J]. Heart Fail Rev, 2019, 24(6): 949-965.
[36]	Schermuly RT, Stasch JP, Pullamsetti SS, et al. Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension[J]. Eur Ｒespir J, 2008, 32(4): 881-891.
[37]	戴志初，张立军. 利奥西呱治疗肺动脉高压疗效及安全性Meta分析[J]. 临床研究, 2017, 26(8): 55-59.
[38]	周立，廖晗静，区景松等. 肺动脉血栓内膜剥脱术治疗慢性栓塞性肺动脉高压[J]. 中华肺部疾病杂志, 2015, 8(4): 452-455.
[39]	Ogo T, Fukuda T, Tsuji A, et al. Efficacy and safety of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension guided by conebeam computed tomography and electrocardiogramgated area detector computed tomography[J]. Eur J Radiol, 2017, 89: 270-276.
[40]	Ogawa A, Satoh T, Fukuda T, et al. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension:results of a multicenter registry[J]. Circ Cardiovasc Qual Outcomes, 2017, 10(11): e004029.
[41]	Inami T, Kataoka M, Kikuchi H, et al. Balloon pulmonary angioplasty for symptomatic chronic thromboembolic disease without pulmonary hypertension at rest[J]. Int J Cardiol, 2019, 15(289): 116-118.
[42]	Kataoka M, Inami T, Kawakami T, et al. Balloon pulmonary angioplasty (percutaneous transluminal pulmonary angioplasty) for chronic thromboembolic pulmonary hypertension:a Japanese perspective[J]. JACC Cardiovasc Interv, 2019, 12(14): 1382-1388.
[43]	洪城，陈海明，罗福全等. 光学相干断层扫描辅助经皮肺血管成形术治疗慢性血栓栓塞性肺动脉高压一例[J]. 中华结核和呼吸杂志, 2018, 41(7): 581-583.
[44]	刘子怡，梁斌. C臂CT在介入放射学中的应用进展[J]. 影像诊断与介入放射学, 2020, 29(1): 60-65.

[1]	叶家欣, 丁一, 陈成, 陈涛, 陆立冲, 葛敏. 体外膜肺氧合在慢性血栓栓塞性肺动脉高压患者血栓内膜剥脱术围术期的应用[J]. 中华重症医学电子杂志, 2018, 04(03): 275-280.
[2]	王凤, 胡晓芸, 张叶钦. 慢性血栓栓塞性肺动脉高压治疗的新进展[J]. 中华临床医师杂志(电子版), 2017, 11(20): 2335-2339.
[3]	王金志, 陶新曹, 谢万木, 傅志辉, 赵蕴伟, 黄强, 翟振国. 球囊肺动脉成形术在慢性血栓栓塞性肺动脉高压治疗中的进展[J]. 中华介入放射学电子杂志, 2023, 11(03): 262-267.
[4]	周阳逸, 顾建平, 汪涛. 球囊肺动脉成形术治疗慢性血栓栓塞性肺动脉高压的现状[J]. 中华介入放射学电子杂志, 2020, 08(02): 184-188.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Treatment of chronic thromboembolic pulmonary hypertension

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Treatment of chronic thromboembolic pulmonary hypertension